Emmaus Life Sciences (EMMA) Return on Sales [ROS] (2010 - 2026)
Emmaus Life Sciences (EMMA) reported Return on Sales [ROS] of 60.00% for Q2 2026, up 73.14 percentage points from -13.13% a year earlier and up 101.53 percentage points from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Emmaus Life Sciences' Return on Sales [ROS] came in at 29.29%, up 37.05 percentage points year-over-year; for FY2025, it was 1.85%, up 13.23 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +1.99 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -11.37% in FY2024 (-23.33 pp), 11.96% in FY2023 (+47.77 pp), -35.81% in FY2022 (-6.08 pp) and -29.73% in FY2021 (-29.60 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q3 2010.
- Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of +17.61 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2022 (a gain of 140.49 percentage points); the low point was Q4 2021 (a drop of 170.18 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -41.52% (Q1 2026), 23.00% (Q4 2025) and 20.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 60.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.00% |
| Mar 31, 2026 | -41.52% |
| Dec 31, 2025 | 23.00% |
| Sep 30, 2025 | 20.57% |
| Jun 30, 2025 | -13.13% |
| Mar 31, 2025 | -40.73% |
| Dec 31, 2024 | -16.92% |
| Sep 30, 2024 | 14.99% |
| Jun 30, 2024 | 10.82% |
| Mar 31, 2024 | -109.34% |
| Dec 31, 2023 | 19.17% |
| Sep 30, 2023 | 0.48% |
| Jun 30, 2023 | 30.91% |
| Mar 31, 2023 | -17.25% |
| Dec 31, 2022 | -23.91% |
| Sep 30, 2022 | -13.36% |
| Jun 30, 2022 | -33.59% |
| Mar 31, 2022 | -94.87% |
| Dec 31, 2021 | -164.40% |
| Sep 30, 2021 | -0.54% |
API Access
Emmaus Life Sciences Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();